Kyverna Therapeutics(KYTX.US)

Last Updated 19:00:00 ET
longbridge loading

Kyverna names CFO Gregory S. Martini in initial beneficial ownership filing

PUBT·
US
KYTX
-1.49%
US
LABU
+11.76%
US
FBT
+2.14%
PUBT·
US
KYTX
-1.49%
US
LABU
+11.76%
US
FBT
+2.14%

Wells Fargo Remains a Buy on Kyverna Therapeutics, Inc. (KYTX)

Tip Ranks·
US
KYTX
-1.49%
US
FBT
+2.14%
US
BBH
+0.96%
Tip Ranks·
US
KYTX
-1.49%
US
FBT
+2.14%
US
BBH
+0.96%

Kyverna Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
KYTX
-1.49%
Earnings Watch·
US
KYTX
-1.49%

Kyverna Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
KYTX
-1.49%
Earnings Watch·
US
KYTX
-1.49%

Kyverna Therapeutics (KYTX) to Release Earnings on Tuesday

Market Beat·
US
KYTX
-1.49%
US
BIB
+4.98%
US
IBB
+2.27%
Market Beat·
US
KYTX
-1.49%
US
BIB
+4.98%
US
IBB
+2.27%
© 2026 Longbridge｜Disclaimer